Anika Therapeutics is a global joint preservation company. Co. is focused on orthopedics, including: Osteoarthritis Pain Management, which consists of Monovisc and Orthovisc, Cingal, and Hyvisc; Joint Preservation and Restoration, which include bone preserving joint technologies, soft tissue repair and regenerative solutions; and Non-Orthopedic, which consists of Hyalobarrier, an anti-adhesion barrier indicated for use after abdomino-pelvic surgeries, Hyalomatrix, which is used for the treatment of complex wounds such as burns and ulcers, as well as products used in connection with the treatment of ears, nose and throat disorders, and ophthalmic products. We show 61 historical shares outstanding datapoints in our coverage of ANIK's shares outstanding history.
Understanding the changing numbers of ANIK shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like ANIK versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching ANIK by allowing them to research ANIK shares outstanding history
as well as any other stock in our coverage universe. |
Free ANIK Email Alerts:
Video: Shares Outstanding Importance
